Playlist

Turkmenistan Forecasts Rainy Weather and Temperatures Reaching 32°C

13 Apr. 05:17

Source

The Ministry of Environmental Protection of Turkmenistan has released a weather update indicating a period of atmospheric instability across the country. Residents should expect overcast skies and rainfall in most regions, accompanied by shifting winds. Despite the rainy conditions, a significant heatwave is expected to push temperatures as high as 32°C in the southern and eastern parts of the nation.

In Ashgabat and the Ahal region, the weather will be dominated by variable cloudiness and intermittent showers. Strong northwesterly winds are predicted to reach speeds of up to 19 meters per second, potentially causing localized dust storms. While nights in Ahal will remain relatively cool, ranging from +7°C to +18°C, daytime highs are projected to climb significantly, reaching up to +30°C in some areas.

The Mary and Lebap regions will experience the highest temperatures in the country. Daytime highs are forecast to fluctuate between +27°C and +32°C, bringing an early taste of summer heat despite the expected rainfall. The winds in these eastern provinces will shift from southeastern to northwestern, maintaining moderate to high speeds throughout the day, which may influence the perceived temperature.

The Balkan and Dashoguz regions will also see a mix of rain and variable sun. In the Balkan province, a stark contrast will exist between the coastal areas, where temperatures will hover around a mild +18°C, and inland districts reaching +26°C. Meanwhile, in Dashoguz, the northernmost region, daytime temperatures are expected to rise from a cool +13°C to a warm +30°C, reflecting the dynamic weather patterns currently affecting the entire territory of Turkmenistan.

‌
‌
‌
‌
‌
‌
‌
‌
‌
‌
‌
‌
‌
‌
‌
‌

Simple Vitamin Shows Surprising Results in Pre-Cancerous Blood Conditions, Study Finds

Today in 02:02

Source

Daily high-dose supplementation of vitamin C can significantly reduce mortality risks and help prevent severe medical complications in patients with pre-cancerous blood conditions. Researchers from the Van Andel Institute in the United States and Copenhagen University Hospital in Denmark reached this conclusion following a comprehensive three-year follow-up study. The international "EVITA" trial involved volunteers who were administered 1,000 mg of vitamin C daily over the course of a year, while a control group received a placebo.

Although initial hypotheses suggested vitamin C might directly inhibit abnormal cell proliferation, researchers found its primary benefit lay in strengthening the body, reducing systemic inflammation, and lowering rates of anemia, pneumonia, and internal bleeding. Over the three-year observation period, the vitamin C group exhibited a significantly higher survival rate compared to the placebo group. While experts emphasize that these findings remain preliminary and require larger clinical trials before reshaping formal medical treatment protocols, vitamin C continues to show promising potential in supportive patient care.

‌
‌
‌
‌
‌
‌
‌
‌
‌
‌
‌
‌
‌
‌
‌
‌